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The  secondary  metabolites  of  higher  plants  include  diverse  chemicals,  such  as  alkaloids, 
isoprenoids  and  phenolic  compounds  (phenylpropanoids  and  flavonoids).  Although  these 
compounds  are  widely  used  in  human  health  and  nutrition,  at  present  they  are  mainly 
obtained  by  extraction  from  plants  and  extraction  yields  are  low  because  most  of  these 
metabolites accumulate at low levels in plant cells. Recent advances in synthetic biology and 
metabolic engineering have enabled tailored production of plant secondary metabolites in 
microorganisms, but these methods often require the addition of expensive substrates. Here 
we develop an Escherichia coli fermentation system that yields plant alkaloids from simple 
carbon sources, using selected enzymes to construct a tailor-made biosynthetic pathway. In 
this system, engineered cells cultured in growth medium without additional substrates produce 
the plant benzylisoquinoline alkaloid, (S)-reticuline (yield, 46.0 mg l − 1 culture medium). The 
fermentation platform described here offers opportunities for low-cost production of many 
diverse alkaloids. 
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T
he secondary metabolites of higher plants include diverse 
chemicals, such as alkaloids, isoprenoids and phenolic com-
pounds (phenylpropanoids and flavonoids), which are pro-
duced from primary metabolites such as amino acids or acetyl-CoA 
(Supplementary Fig. S1). Although these compounds are widely 
used in human health and nutrition, at present they are mainly 
obtained by extraction from plants. However, extraction yields are 
low because most of these metabolites accumulate at low levels in 
plant cells. There have been many attempts to use plant metabolic 
engineering  to  increase  the  amounts  of  secondary  metabolites. 
However, it is very difficult to obtain the desired products because 
of the complex and strict regulation of their biosynthesis. Chemical 
synthesis has also been used to produce plant secondary metabo-
lites; however, the complexity and chirality of these compounds 
have hampered the development of cost-effective methods.
Recently, there has been increasing interest in microbial pro-
duction  of  plant  secondary  metabolites  by  reconstructing  their 
biosynthetic pathways in microorganisms1–5. Among these metabo-
lites, isoprenoids are produced from acetyl-CoA in the mevalonate 
pathway  or  glyceraldehyde-3-phosphate  and  pyruvic  acid  in  the   
1-deoxy-d-xylulose-5-phosphate pathway (Supplementary Fig. S1). 
The biosynthesis of isoprenoids is well characterized, and they have 
been produced by microbes in a simple growth medium6. The other 
major groups of secondary metabolites, that is, alkaloids and phe-
nolic compounds, are derived from aromatic amino acids (Supple-
mentary Fig. S1). These compounds can be produced via microbial 
fermentation, but such systems require the addition of expensive 
precursor chemicals7–9, which makes these methods commercially 
unfeasible. Production of alkaloids and phenolic compounds from 
an inexpensive and readily available material has been one of the 
most important challenges for metabolic engineering of secondary 
metabolites10,11.
Alkaloids are low-molecular-weight, nitrogen-containing com-
pounds that are found in ~20% of plant species. They are very impor-
tant in medicine because of their high biological activities. Most 
alkaloids are derived from amines produced by the decarboxylation 
of amino acids, such as histidine, lysine, ornithine, tryptophan and 
tyrosine. One of the largest and most diverse groups of pharma-
ceutically important alkaloids is the benzylisoquinoline alkaloids 
(BIAs). BIAs, which include the analgesic compounds morphine 
and codeine and the antibacterial agents berberine and palmatine, 
are produced through (S)-reticuline from l-tyrosine. Thus, (S)-reti-
culine is a main branch-point intermediate in the biosynthesis of 
many types of BIAs, and also acts as a non-narcotic building block 
that is useful in the development of novel antimalarial and antican-
cer drugs. In this study, we focused on the fermentative produc-
tion of (S)-reticuline in Escherichia coli grown in a simple medium   
without additional substrates.
Here we constructed a bacterial platform for plant alkaloid pro-
duction from simple carbon sources. In this platform, a tailor-made 
alkaloid biosynthetic pathway from l-tyrosine was constructed in   
l-tyrosine  over-producing  E.  coli  cells.  The  recombinant  strain 
could produce 46.0 mg l − 1 of (S)-reticuline from glycerol, suggesting 
that the fermentation platform would enable low-cost production of 
many diverse alkaloids.
Results
Design  of  an  artificial  BIA  biosynthetic  pathway.  We  have 
already succeeded in synthesizing reticuline from dopamine7. Thus, 
to  obtain  BIAs  from  a  simple  medium  without  the  addition  of 
dopamine, there are two additional steps that must be introduced: 
fermentative production of l-tyrosine and conversion of l-tyrosine 
to dopamine. We first generated an E. coli strain that over-produces 
l-tyrosine by amino-acid fermentation. This was accomplished by 
three steps of genetic engineering. An E. coli strain has disrupted 
the tyrR gene, the product of which represses the expression of 
genes involved in aromatic amino-acid biosynthesis12. In addition, 
the  feedback-inhibition-resistant  (fbr)  3-deoxy-d-arabino-
heptulosonate-7-phosphate (DAHP) synthase (fbr-DAHPS: aroGfbr) 
and  fbr-chorismate  mutase/prephenate  dehydrogenase  (fbr-CM/
PDH:  tyrAfbr)  are  overexpressed  in  the  shikimic  acid  pathway13. 
To  increase  metabolic  flow  into  the  shikimic  acid  pathway, 
phosphoenolpyruvate  synthetase  (PEPS:  ppsA)  and  transketolase 
(TKT:  tktA)14  are  exogenously  introduced  (Fig.  1).  Thus,  the   
l-tyrosine  over-producing  E.  coli  strain  contains  a  knockout 
mutation in tyrR and a plasmid expressing the aroGfbr, tyrAfbr, ppsA 
and tktA genes (Supplementary Fig. S2). The engineered E. coli cells 
produced l-tyrosine in the medium at a yield of ~4.37 ± 0.17 g l − 1 
(24.0 ± 0.94 mM;  average  yield ± standard  deviation  from  three 
independent experiments), when glycerol was used as the carbon 
source. The overall yield of l-tyrosine, when glycerol was used as a 
carbon source, was 29.5% (molar ratio). By contrast, the wild-type 
E. coli cells produced low quantities of l-tyrosine in culture.
The BIA synthetic pathway of plants has not been completely   
elucidated. The pathway to dopamine or 4-hydroxyphenylacetal-
dehyde  (4-HPAA)  from  l-tyrosine  is  proposed  in  Figure  2,  but 
not all of the enzymes have been identified as yet. We originally 
designed an artificial pathway of reticuline synthesis using micro-
bial enzymes. In plants and animals, l-DOPA is mainly synthesized 
from l-tyrosine by tyrosine hydroxylase (EC 1.14.16.2); however, 
tetrahydrobiopterin (BH4) is required as a cofactor for this reac-
tion. E. coli cannot synthesize BH4; therefore, to convert l-tyro-
sine to l-DOPA, we chose tyrosinase (TYR; EC 1.14.18.1), which 
is unrelated to BIA biosynthesis. The TYRs from humans, Pholiota 
nameko  and  Streptomyces  castaneoglobisporus  were  expressed  in   
E. coli cells, and we examined their ability to convert l-tyrosine into   
l-DOPA. Only the TYR from S. castaneoglobisporus (ScTYR) success-
fully converted l-tyrosine into l-DOPA, and did not require unique 
cofactors other than copper and an adaptor protein (ORF378)15,16. 
When  the  selected  TYR  was  expressed  in  the  l-tyrosine  over- 
producing E. coli strain, l-DOPA was produced in the medium at a 
yield of 293 ± 5.9 mg l − 1. The conversion efficiency from l-tyrosine 
to l-DOPA was 6.19 ± 0.13%.
In  our  synthetic  pathway,  dopamine  was  synthesized  from   
l-DOPA by the decarboxylation reaction (Fig. 1). It is important 
that only l-DOPA undergoes decarboxylation. If other aromatic 
amines  were  produced  by  decarboxylation,  monoamine  oxidase 
(MAO; EC 1.4.3.4) would act on these amines to produce their 
corresponding  aldehydes,  which  could  then  be  accepted  in  the 
coupling reaction catalysed by norcoclaurine synthase (NCS; EC 
4.2.1.78). Because MAO shows greater activity towards tyramine 
than dopamine, it was important to select an  enzyme that spe-
cifically decarboxylates l-DOPA, not l-tyrosine; otherwise, MAO 
would  act  on  tyramine  produced  by  the  decarboxylation  of   
l-tyrosine, and the resulting 4-HPAA could then be accepted in the   
coupling reaction with dopamine catalysed by NCS. The coupling 
product, (S)-norcoclaurine, is converted to (S)-N-methylcoclaurine 
by norcoclaurine 6-O-methyltransferase (6OMT) and coclaurine-
N-methyltransferase  (CNMT).  Because  3′-hydroxy-N-methylco-
claurine-4′-O-methyltransferase (4′OMT) has no ability to catalyse 
(S)-N-methylcoclaurine17, the synthetic flow constructed in the cells 
terminated at (S)-N-methylcoclaurine because of the lack of cyto-
chrome P450 hydroxylase (CYP80B) in our system (Figs 1 and 2). 
In the plant BIA biosynthetic pathway, tyrosine/DOPA decarboxy-
lase (EC 4.1.1.25) catalyses the decarboxylation of l-tyrosine and 
l-DOPA to tyramine and dopamine, respectively18 (Fig. 2). For this 
reason, we selected the l-DOPA-specific decarboxylase (DODC; EC 
4.1.1.28) from Pseudomonas putida strain KT2440, which exhibited 
a more than 103-fold preference for l-DOPA than for other aromatic 
amino acids (Koyanagi T. et al., in preparation). When the selected 
TYR and DODC were expressed in the l-tyrosine over-producing 
E. coli strain, dopamine was produced in the medium at a yield of ARTICLE     
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~260 ± 22.7 mg l − 1.  The  conversion  efficiency  from  l-tyrosine  to 
dopamine was 7.08 ± 0.62%, which was slightly improved compared 
with that from l-tyrosine to l-DOPA. The amount of melanin-like 
pigment in the culture medium of a dopamine-producing strain   
was lower than that in a l-DOPA-producing strain (Supplementary 
Fig. S3). It was suggested that l-DOPA was converted into dopamine 
by DODC before the reaction of l-DOPA into dopaquinone. The 
Km value for l-DOPA of ScTYR was 8.1 mM (ref. 15). By con-
trast, the Km value for l-DOPA of P. putida DODC was 0.092 mM   
(Koyanagi T. et al., in preparation). It was indicated that P. putida 
DODC dominates ScTYR in the reaction of l-DOPA, and the com-
bination of TYR and DODC enables the conversion of l-tyrosine to 
dopamine with reducing dopaquinone formation.
In the final step of the fermentative production of (S)-reticuline, 
we combined the dopamine-producing pathway described above 
with the synthetic pathway from dopamine to (S)-reticuline7. The 
genes encoding NCS and MAO were inserted into the pET-21d   
vector together with the genes for TYR and DODC. The genes for 
6OMT, 4′OMT and CNMT were inserted into the pACYC184 vec-
tor (Supplementary Fig. S2). The natural biosynthetic pathway in 
plants is not necessarily suitable for a microbial production system; 
therefore, our designed synthetic pathway differs from the original 
biosynthetic pathway. We carefully designed and optimized an arti-
ficial BIA pathway consisting of genes that were unrelated to the 
natural biosynthetic pathway (Fig. 1). The newly designed pathway 
comprises one E. coli gene knockout, four overexpressed genes and 
eight exogenous genes. Our system uses selected enzymes to con-
struct a single pathway from l-tyrosine to (S)-norlaudanosoline. 
This system circumvents the complicated branched pathway and a 
potentially problematic CYP reaction in bacteria (Figs 1 and 2).
(S)-Reticuline production from a simple carbon source. Liquid 
chromatography–mass  spectrometry  (LC–MS)  analysis  showed 
Figure 1 | Bacterial BIA biosynthetic pathway constructed in Escherichia coli 
cells. For l-tyrosine over-production, four enzymes (TKT, PEPS,  
fbr-DAHPS and fbr-CM/PDH) are overexpressed. Black box indicates the 
common aromatic pathway. The tailor-made biosynthetic pathway (blue) 
consisted of TYR, DoDC and MAo. The plant biosynthetic pathway (red) 
was modified to circumvent the CYP80B reaction. CNMT, coclaurine-N-
methyltransferase of Coptis japonica (GenBank accession number AB061863); 
DAHPS, 3-deoxy-d-arabino-heptulosonate-7-phosphate synthase (aroGfbr, 
GenBank accession number J01591); DoDC, DoPA decarboxylase 
of Pseudomonas putida (GenBank accession number AE015451); E4P, 
erythrose-4-phosphate; fbr, feedback-inhibition-resistant; fbr-CM/PDH, fbr-
chorismate mutase/prephenate dehydrogenase (tyrAfbr, GenBank accession 
number M10431); HPP, 4-hydroxyphenylpyruvate; MAo, monoamine 
oxidase of Micrococcus luteus (GenBank accession number AB010716); 
NCS, norcoclaurine synthetase of C. japonica (GenBank accession number 
AB267399); PEPS, phosphoenolpyruvate (PEP) synthetase (ppsA, GenBank 
accession number X59381); TKT, transketolase (tktA, GenBank accession 
number X68025); TYR, tyrosinase of Streptomyces castaneoglobisporus (ScTYR 
containing tyrosinase and its adaptor protein, oRF378, GenBank accession 
numbers AY254101 and AY254102) or tyrosinase of Ralstonia solanacearum 
(RsTYR, Rcs0337, GenBank accession number AL646052); 3,4-DHPAA, 3,4-
dihydroxyphenylacetaldehyde; 6oMT, norcoclaurine 6-O-methyltransferase 
of C. japonica (GenBank accession number D29811); 4′oMT, 3′-hydroxy-N-
methylcoclaurine 4′-O-methyltransferase of C. japonica (GenBank accession 
number D29812).
Figure 2 | Proposed plant biosynthetic pathway and genes involved in the 
biosynthesis of BIAs from l-tyrosine to (S)-reticuline. CYP80B,  
N-methylcoclaurine 3′-hydroxylase; NCS, norcoclaurine synthase;  
TH, tyrosine hydroxylase; TYDC, tyrosine/dopa decarboxylase; 
4-HPAA, 4-hydroxyphenylacetaldehyde; 6oMT, norcoclaurine 6-O-
methyltransferase; 4′oMT, 3′-hydroxy-N-methylcoclaurine 4′-O-
methyltransferase.ARTICLE
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that engineered E. coli cells produced up to 2.26 mg l − 1 (average of 
2.00 ± 0.28 mg l − 1  from  three  independent  experiments)  (S)-reti-
culine from glucose in the culture medium (Fig. 3a,b). Without   
glucose,  the  yield  of  (S)-reticuline  was  low  (80 µg l − 1),  indicat-
ing that (S)-reticuline was derived from a simple carbon source, 
glucose. The amount of (S)-reticuline production was reduced to 
one-quarter in the wild-type E. coli cells with the synthetic pathway 
from l-tyrosine to (S)-reticuline. This result confirmed that meta-
bolic engineering of the aromatic amino-acid pathway effectively 
produced secondary metabolites from a simple carbon source. The 
growth rate of recombinant E. coli cells indicated that the interme-
diates in the reticuline biosynthetic pathway or (S)-reticuline did 
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Figure 3 | Fermentative production of (S)-reticuline. (a) Time course of (S)-reticuline production in Escherichia coli cultures. l-Tyrosine over-producing  
E. coli (red circles) or wild-type strains (blue squares) harbouring NCS-ScTYR-DODC-optMAO/pET-21d and 6OMT-4′OMT-CNMT/pACYC184 were grown 
in a jar fermenter. In the case of an l-tyrosine over-producing strain, the culture was carried out in medium with (red circles) or without glucose (green 
triangles). Cell growth (broken lines with the same symbols as those for (S)-reticuline production) is represented as the optical density at 600 nm. The 
arrow indicates addition of IPTG (50 µM) at the indicated time. Data are representative of three independent experiments. (b) LC–MS/MS analysis of 
the reaction product from our system. Selected-ion monitoring (SIM) parameter: m/z = 330 (reticuline). (c) Effect of IPTG concentration on fermentative 
production of (S)-reticuline in glucose-based medium. The E. coli strain over-producing l-tyrosine and expressing reticuline biosynthetic genes was 
grown until the oD600 was 10 before the addition of IPTG (arrow). No IPTG induction (blue squares), 50 µM (red circles), 150 µM (green triangles) or 
500 µM IPTG (purple crosses). Data are representative of three independent experiments. (d) Fermentative production of (S)-reticuline in glycerol-based 
medium. A reticuline-producing strain using ScTYR (blue squares) or RsTYR (red circles) was cultured. The arrow indicates addition of IPTG (50 µM) 
at the indicated time. Cell growth (broken lines with the same symbols as those used for (S)-reticuline production) is represented as the optical density 
at 600 nm. The error bar indicates the standard deviation of three independent experiments. (e, f) Analysis of stereoselectivity of the reaction product 
towards (R,S)-reticuline. Authentic (R,S)-reticuline (e) and the reaction product in cultures of E. coli cells expressing biosynthetic genes (f) were analysed 
by LC–MS. SIM parameter: m/z = 330 (reticuline).ARTICLE     
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not inhibit the growth of E. coli cells. In this system, (S)-reticuline 
was  produced  by  leaky  expression  of  biosynthetic  genes  with-
out  induction  by  isopropyl-β-d-thiogalactoside  (IPTG;  Fig.  3c), 
which substantially reduces production costs. When glycerol was 
used as the carbon source, (S)-reticuline production increased up 
to 6.24 mg l − 1 (average of 5.92 ± 0.36 mg l − 1 from three independent 
experiments) within 80 h (Fig. 3d), which was three times higher 
than the amount produced in the glucose-based medium. It was 
reported that glycerol is a more suitable carbon source than glucose 
for the production of shikimic acid and l-phenylalanine19,20. There-
fore, it is likely that glycerol is also a more suitable carbon source 
for BIA production, as is the case for other products related to the 
shikimic acid pathway. The conversion efficiency from l-tyrosine 
to (S)-reticuline was 0.150 ± 0.01%, which is much lower than that 
for dopamine. To investigate the low conversion efficiency of (S)-
reticuline production, the amount of intermediate compounds, the 
expression levels of the biosynthetic genes (TYR, ORF378, DODC, 
MAO, NCS, 6OMT, CNMT and 4′OMT), and the degradation of 
dopamine,  norlaudanosoline  and  (S)-reticuline  in  culture  were 
examined. l-Tyrosine was not increased during growth, and other 
intermediate compounds (l-DOPA, dopamine and intermediated 
BIAs) were not observed in the culture medium (Supplementary 
Fig. S4), indicating that metabolic flow to reticuline was not inter-
rupted.  Reverse  transcription  PCR  (RT–PCR)  results  indicated 
that all biosynthetic genes were expressed (Fig. 4). The expression 
levels of plant genes (NCS, 6OMT, CNMT and 4′OMT) were low 
compared with microbial genes. The expression level of DODC was 
higher than that of TYR, which enables the conversion of l-DOPA 
to dopamine. The degradation analysis was carried out by adding 
substrates at a concentration close to that of the production yield 
to the culture medium. As a result, dopamine and norlaudano-
soline were much more unstable than reticuline (Supplementary   
Fig. S5). These observations, together with the fact that interme-
diated compounds were not accumulated (Supplementary Fig. S4), 
indicated that the low yield of (S)-reticuline from dopamine was 
attributed to the instability of dopamine and norlaudanosoline, and 
to a lesser extent, the inefficient conversion of l-tyrosine to l-DOPA. 
The increase in expression levels of plant genes could improve the 
usage efficiency of dopamine and norlaudanosoline. Although TYR 
catalyses the oxidation of l-tyrosine to l-DOPA, TYR also has the 
ability to convert l-DOPA or dopamine to its quinone derivative 
(o-diphenolase), which is easily oxidized and polymerizes to form 
a  melanin  pigment.  In  our  system,  a  melanin-like  pigment  was 
produced in the culture medium (Supplementary Fig. S3). There-
fore, we speculated that the instability of intermediate compounds 
might be attributed to o-diphenolase activity via TYR reactions. It 
has been reported that TYR from Ralstonia solanacearum (RsTYR)   
possesses low o-diphenolase activity21. This report prompted us to 
integrate RsTYR into our platform instead of ScTYR. As expected, 
the platform containing RsTYR produced up to 46 mg l − 1 (average of 
40.5 ± 4.8 mg l − 1 from three independent experiments) of reticuline, 
a yield approximately seven times higher than the platform using 
ScTYR  (Fig.  3d).  Because  the  dopamine-producing  strain  using 
RsTYR produced 1.05 ± 0.05 g l − 1 (6.85 ± 0.30 mM) of dopamine, a 
yield almost four times higher than the dopamine-producing strain 
using ScTYR, the increased production ability of dopamine might 
contribute to increased reticuline production.
Although  NCS  is  an  (S)-form  specific  enzyme,  reticuline 
was produced as a racemate in our previous system7 because of   
a  spontaneous  condensation  reaction  involving  dopamine  and   
3,4-dihydroxyphenylacetaldehyde to form (R,S)-norlaudanosoline. 
The newly constructed system produced the (S)-form exclusively   
(Fig.  3e,f).  Furthermore,  even  when  NCS  was  absent  from  our 
platform, which produced (R,S)-norlaudanosoline by a spontane-
ous  condensation  reaction,  (R)-reticuline  could  not  be  detected   
(Fig. 5a,b). According to analysis of the reticuline production sys-
tem from norlaudanosoline, (R)-reticuline was detected only when 
a  small  amount  of  norlaudanosoline  was  added  to  the  culture   
(Fig. 5c–f). These results led us to speculate that (S)-reticuline accu-
mulates because methyltransferases (6OMT, CNMT and 4′OMT) 
react to the (S)-form in a superior manner to the (R)-form, or that 
the (R)-form ceases to be modified or degraded in E. coli cells. A 
larger amount of norlaudanosoline was available for reticuline pro-
duction in our new platform compared with the dopamine-adding 
system7; therefore, production of (R)-reticuline was not observed 
in the newly constructed platform. The fermentative system devel-
oped in this study can produce optically active (S)-reticuline rapidly   
(that is, in a few days) compared with fermentation systems using 
cultured plant cells or transgenic plants (months to years).
The fermentation strategy for secondary metabolites described 
here  requires  cultivation  of  engineered  cells  in  simple  growth 
medium without additional substrates. Therefore, this system will 
drastically reduce the costs of producing scarce secondary metabo-
lites. The glucose or glycerol used in this system is inexpensive and 
readily available, compared with the additional substrates that were 
required in previous microbial systems, such as dopamine or nor-
laudanosoline7,8. Although the overall yield of (S)-reticuline in this 
system was low, we estimate that the production cost of (S)-reti-
culine using this method would be much lower than that of previous 
microbial systems in terms of substrate costs. In addition to reduced 
production costs, another advantage of this system is the simple and 
effective purification procedure, which results in (S)-reticuline with 
little contamination by other undesired BIAs. (S)-Reticuline was 
purified from the culture medium using solid-phase extraction and 
high-performance liquid chromatography (HPLC; Supplementary 
Fig. S6). This procedure recovered more than 90% of purified (S)-
reticuline in two steps. A simple purification procedure resulting in 
high yields makes this production system economically viable.
Discussion
In  plants,  the  secondary  metabolite  biosynthetic  pathway  is 
branched, complicated and difficult to reconstruct in a microbial 
production system. In this study, we first demonstrated the feasi-
bility of fermentative production of a plant alkaloid from a simple 
carbon source, using selected enzymes to construct a tailor-made 
biosynthetic pathway in an l-tyrosine over-producing E. coli strain. 
We succeeded in (S)-reticuline production by converting l-tyrosine 
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to dopamine with a combination of selected TYR and DODC, and 
constructing a synthetic pathway from dopamine to a BIA skeleton 
using microbial MAO. (S)-Reticuline is contained at low amount in 
natural plant, because it is an intermediated compound in BIA bio-
synthetic pathway. It was reported that (S)-reticuline accumulated 
at high level in latex of transgenic opium poppy, which has antisense 
berberine bridge enzyme gene22. The amount of (S)-reticuline accu-
mulation was estimated ~320 mg per 1 l of latex over 60 days22,23.   
In the case of our platform, (S)-reticuline accumulated about 40 mg 
per 1 l of culture medium within 3 days. In general, extraction of 
chemical compounds from plant sources has some problems, such 
as time cost, troublesome for collecting, difficult scale-up proce-
dure. It was suggested that our bacterial platform would be more 
suitable for reticuline production than extraction procedure from 
plant sources.
In our system, we produced (S)-reticuline, which is a branch-
point intermediate in the biosynthesis of many types of BIAs. There-
fore, our bacterial platform can be used to produce (S)-reticuline 
derivatives by chemosynthesis from (S)-reticuline or by transform-
ing the engineered strain with biosynthetic genes required for the 
target  compound.  Recently,  two  key  enzymes  in  the  morphine 
biosynthetic  pathway,  thebaine  6-O-demethylase  and  codeine   
O-demethylase, have been identified24. Therefore, the biosynthetic 
genes in the morphine biosynthetic pathway from (R)-reticuline 
to  morphine  have  been  isolated  and  characterized  completely. 
Morphine  alkaloids  are  synthesized  from  (S)-reticuline  via  (R)-
reticuline,  which  is  a  two-step  isomerization  reaction  catalysed 
by  1,2-dehydroreticuline  synthase  and  1,2-dehydroreticulinium 
reductase25,26.  Although  the  biosynthetic  genes  responsible  for   
converting  (S)-reticuline  to  (R)-reticuline  have  not  been  identi-
fied, our dopamine-adding system is able to produce reticuline as 
a racemate by using E. coli cells expressing reticuline biosynthetic 
genes without NCS7. In plant secondary metabolism, CYPs are one 
of the most important groups of biosynthetic enzymes. The expres-
sion and function of plant CYPs is potentially problematic in a 
microbial production system. However, the successful expression of 
plant CYPs in a microbial host such as E. coli, with modification of 
the amino-terminal region, has recently been reported27. Including 
these biosynthetic genes containing CYPs in our microbial fermen-
tation system may achieve production of morphine alkaloids from 
simple carbon sources by (R,S)-reticuline.
Furthermore,  because  bacterial  fermentation  systems  have 
advanced metabolic engineering for the production of amino acids, 
our platform could be further developed to produce other second-
ary metabolites. As an example, l-phenylalanine and l-tryptophan 
were easily over-produced in our system by overexpression of the 
branched pathway genes (trp operon or pheA) from chorismate to 
l-phenylalanine or l-tryptophan, respectively28. Indole alkaloids, 
which are the most structurally diverse alkaloids along with BIAs, 
are synthesized from l-tryptophan and secologanin, with several 
biosynthetic  genes  isolated  and  characterized5.  The  isolation  of 
genes early in the pathway to secologanin enables our system to be 
expanded with respect to applications for metabolic engineering of 
many indole alkaloids (Supplementary Fig. S1). Various phenolic 
compounds have been successfully produced from l-phenylalanine 
and  l-tyrosine  in  microbial  systems9.  The  fermentation  system 
described here is easily applicable for metabolic engineering of phe-
nolic compounds (Supplementary Fig. S1). Many diverse second-
ary metabolites are derived from aromatic amino acids or acetyl-
CoA; therefore, the fermentation platform described here illustrates 
a general strategy of metabolic engineering for the production of 
secondary metabolites, especially aromatic amino-acid derivatives. 
Combined with the fermentation platform for the production of 
isoprenoids6, our platform represents a significant advance in the 
metabolic engineering of secondary metabolites.
Methods
Materials. All synthetic genes were obtained from GenScript. (R,S)-Norlaudano-
soline was purchased from Acros Organics. l-Tyrosine, l-DOPA and dopamine 
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Figure 5 | Analysis of stereoselectivity of the reaction product towards 
(R,S)-reticuline. Authentic (R,S)-reticuline (a), the reaction product in the 
culture of the reticuline-producing strain without NCS (b), the reaction product 
in the culture of BL21DE3 cells harbouring 6OMT-4′OMT-CNMT/pACYC184 (a 
plasmid for producing reticuline from norlaudanosoline) (c–f), were analysed 
by LC–MS. Selected-ion monitoring (SIM) parameter: m/z = 330 (reticuline). 
BL21DE3 cells harbouring 6OMT-4′OMT-CNMT/pACYC184 were grown in 
LB medium at 25 °C until the oD600 reached 0.5. Then, 1 mM of IPTG and the 
indicated concentration, 10 µM (c), 30 µM (d), 100 µM (e) and 300 µM (f) of 
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were purchased from Sigma-Aldrich. (R,S)-Reticuline was a gift from Mitsui 
Chemicals.
Construction of expression vectors. Construction of an E. coli strain over-
producing L-tyrosine was achieved by the following steps: disruption of the tyrR 
gene12; overexpression of fbr-DAHPS (aroGfbr) and fbr-CM/PDH (tyrAfbr) in the 
shikimic acid pathway13; and increasing the metabolic flows into the shikimic acid 
pathway by overexpressing PEPS (ppsA) and TKT (tktA)14 (Fig. 1). We constructed 
an expression vector containing tyrAfbr, aroGfbr, tktA and ppsA. The genes tyrAfbr and 
aroGfbr cloned into pUC57 were purchased from GenScript and tyrAfbr was flanked 
by NcoI and EcoRI restriction enzyme recognition sites, and aroGfbr was fused to 
the T7 promoter. An EcoRI site was located upstream of the T7 promoter, and a 
SacI site was located downstream of aroGfbr. The tktA and ppsA genes were ampli-
fied from genomic DNA of E. coli K-12 MG1655 using the primer sets NdeI-tktA-F 
and tktA-XhoI-R, and NdeI-ppsA-F and ppsA-XhoI-R, respectively (Supplemen-
tary Table S1). After digestion with NdeI and XhoI, tktA and ppsA were individually 
cloned into pET-41a (Novagen) and pCOLADuet-1 (Merck), respectively.  
A DNA fragment containing the tyrAfbr gene was excised from tyrAfbr/pUC57 using 
NcoI and EcoRI, and then cloned into pCOLADuet-1. The EcoRI-SacI fragment  
of aroGfbr/pUC57 was cloned into tyrAfbr/pCOLADuet-1, yielding the tyrAfbr-aroGfbr 
expression vector. We amplified tktA under the control of the T7 promoter from 
tktA/pET-41a using the primers 5Sac-T7 and 3NottktA (Supplementary Table S1). 
These were then cloned into tyrAfbr-aroGfbr/pCOLADuet-1, generating tyrAfbr-
aroGfbr-tktA/pCOLADuet-1. Finally, we digested ppsA/pCOLADuet-1 with NotI 
and XhoI to obtain a fragment containing the ppsA gene and the T7 promoter. 
This fragment was then cloned into tyrAfbr-aroGfbr-tktA/pCOLADuet-1, yielding 
tyrAfbr-aroGfbr-tktA-ppsA/pCOLADuet-1 (Supplementary Fig. S2), and its sequence 
was confirmed.
The norlaudanosoline synthetic pathway consists of four enzymes; TYR of  
S. castaneoglobisporus (ScTYR containing TYR and its adaptor protein, ORF378) 
or RsTYR (Rcs0337), DODC of P. putida, MAO of Micrococcus luteus and NCS of 
Coptis japonica. In this study, we used a codon-optimized MAO (optMAO) and 
cloned it into a pGS-21a plasmid from GenScript. The MAO gene used previously 
(NCS-MAO/pKK223-3)7 was replaced by optMAO driven by the T7 promoter. This 
was achieved by integrating the BamHI-HindIII fragment of optMAO and the T7 
promoter generated by PCR using the primers 5Bam-T7 and 3oMAO (Supplemen-
tary Table S1) into NCS-MAO/pKK223-3, generating NCS-optMAO/pKK223-3. 
The PCR product for DODC (NdeI-BamHI fragment, obtained using the primers 
5NdeDODC and 3BamDODC (Supplementary Table S1)) was ligated into the 
cognate site of pET-3a (Novagen). The DODC gene with the T7 promoter was 
amplified from DODC/pET-3a with the primers 5BamSacRVT7 and 3BamDODC 
(Supplementary Table S1), and cloned into NCS-optMAO/pKK223-3. We pur-
chased ScTYR or RsTYR cloned into pGS-21a from GenScript. The PCR product 
for ScTYR or RsTYR (SacI-EcoRV fragment, amplified using primers 5SacI-T7 
and 3pGSEcoRV (Supplementary Table S1)) was ligated into the cognate site of 
NCS-DODC-optMAO/pKK223-3 yielding NCS-TYR-DODC-optMAO/pKK223-3. 
To compare production among lines harbouring different plasmid backbones, we 
generated a pET-21d (Novagen) plasmid-based vector. We amplified the fragment 
containing the T7 promoter fused to NCS from NCS-MAO/pKK223-3 (ref. 7) 
using the primers 5BglII-T7 and 3NCSBamSacRV (Supplementary Table S1). 
The fragment was ligated into the BglII-BamHI site of pET-21d. The SacI-HindIII 
fragment for NCS-DODC-optMAO/pKK223-3, containing DODC-optMAO genes 
was ligated into NCS/pET-21d, generating NCS-DODC-optMAO/pET-21d. Finally, 
the PCR product for TYR was ligated into the SacI-EcoRV site of NCS-DODC-
optMAO/pET-21d, yielding NCS-TYR-DODC-optMAO/pET-21d (Supplementary 
Fig. S2). The line harbouring the pET-21d-based plasmid produced slightly higher 
levels of reticuline (0.14 versus 0.11 mg l − 1 in the small-scale culture); therefore, 
we selected NCS-TYR-DODC-optMAO/pET-21d as the expression plasmid for 
norlaudanosoline pathway enzymes.
To construct the L-DOPA-producing strain, the NdeI-XhoI fragment of 
TYR/pGS-21a was cloned into the cognate site of pET-23a, yielding TYR/pET-23a. 
TYR and DODC (BamHI fragment of NCS-TYR-DODC-optMAO/pET-21d) were 
cloned into pET-23a, yielding TYR-DODC/pET-23a.
Construction of aromatic compound-producing strains. The genetic design of 
the l-tyrosine over-producing strain is described by Lütke-Eversloh and Stepha-
nopoulos14. The markerless deletion of tyrR, tyrRnull strain, was constructed 
by PCR-based method29. BL21 (DE3) tyrRnull was transformed with tyrAfbr-
aroGfbr-tktA-ppsA/pCOLADuet-1, yielding the l-tyrosine over-producing strain. 
To construct the l-DOPA- and dopamine-producing strains, the l-tyrosine 
over-producing strain was transformed with TYR/pET-23a and TYR-DODC/pET-
23a, respectively. To construct the reticuline-producing strain, the l-tyrosine over-
producing strain was transformed with NCS-TYR-DODC-optMAO/pET-21d and 
6OMT-4′OMT-CNMT/pACYC184 (ref. 7; Supplementary Fig. S2).
Fermentation conditions. Cells were cultured overnight in liquid LB medium at 
37 °C, then 10 ml of the cell culture was inoculated into 1 l of modified convention-
al medium (per litre: 47.6 g Turbo Broth (Athena Enzyme System), 1.6 g NH4Cl, 
2.49 mg CuSO4·5H2O, 3 g glucose or 5 g glycerol, and appropriate antibiotics (50 mg 
ampicillin, 25 mg kanamycin and 50 mg chloramphenicol). Cultures were grown at 
25 °C in a 3-l jar fermenter (BMS-03PI, ABLE). The pH was maintained at  
7.1 by automatic addition of 28% NH4OH and 1 M HCl. The agitation speed was 
100 r.p.m. at the time of inoculation, and dissolved oxygen levels were allowed to 
fall to 10% of O2 saturation with continuous air supply of 1 volume per volume 
per minute. The glucose concentration was maintained between 0.1 and 7 g l − 1 by 
addition of 0.5 g ml − 1 glucose solution. The glycerol concentration was maintained 
between 0.1 and 6 g l − 1 by addition of 1 g ml − 1 glycerol solution. If needed, an indi-
cating concentration of IPTG was added to the culture when OD600 reached  
10 (glucose-based medium) or 15 (glycerol-based medium).
Detection and quantification of chemical compounds. Glucose in the culture 
medium was analysed by the mutarotase-glucose method using a Glucose CII Test 
Wako (Wako). Glycerol in the culture medium was analysed using a Glycerol Assay 
Kit (Cayman Chemical). To analyse aromatic compounds in the culture medium, 
except for reticuline and norlaudanosoline, cultures were collected and treated with 
1 N HCl for solving crystallized tyrosine. After centrifugation, samples were ana-
lysed by HPLC equipped with a Discovery HS F5 column (Supelco). Compounds 
were separated on the column by increasing the concentration of acetonitrile from 
3 to 20% in 10 mM ammonium formate (pH 3.0) at a flow rate of 0.5 ml min − 1. Elu-
tion of compounds was monitored by measuring absorbance at 280 nm.
To measure reticuline and norlaudanosoline production, the culture medium 
was collected at various times, and proteins were precipitated with 2% trichloroac-
etate. The supernatant was analysed by LC–MS (3200 Q TRAP, Applied Biosystems 
Japan) after separation on an Agilent HPLC system (Agilent). The HPLC condi-
tions were as follows: column, TSKgel ODS-80Ts (4.6×250 mm; Tosoh); solvent 
system, A: 0.1% acetic acid in water, B: 0.1% acetic acid in acetonitrile; gradient 
modes: 90% A (0–5 min), 90–60% A (5–20 min) and 10% A (20–30 min); flow 
rate, 0.5 ml min − 1 at 40 °C. Reticuline was identified by comparison with authentic 
reticuline with regard to the fragmentation spectrum in LC–MS/MS. The amounts 
of reticuline and norlaudanosoline were estimated from standard curves using 
Analyst 1.4.1 software. Experiments were repeated three times.
The stereoselectivity of reticuline was analysed by LC–MS after separation on 
an Agilent HPLC system. HPLC conditions were as follows: column, CHIRALCEL 
OD-H (4.6×250 mm, Daicel Chemical Industries); solvent system, hexane: 
2-propanol:diethylamine (72:28:0.1); flow rate, 0.55 ml min − 1 at 40 °C.
Quantitative RT–PCR analysis of synthetic pathway genes. The reticuline-
producing strain was grown on glycerol-based medium in a jar fermenter. IPTG 
(50 µM) was added to the culture when OD600 reached 15. For total RNA extrac-
tion, cells were collected at 40 h post-inoculation. Total RNA was extracted using 
an RNeasy Mini kit (Qiagen). To eliminate contaminated DNA, we used DNaseI 
treatment system included in RNAqueous-4PCR Kit (Ambion). A total of 1.5 µg 
total RNA was used in reverse transcription reactions using a High Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems).
Relative RNA concentrations were determined by quantitative RT–PCR using 
a 7300 Real-time PCR system with TaqMan Gene Expression Assay (Applied 
Biosystems). Primers and probes were designed using Primer Express 1.5 software 
(Perkin-Elmer; Supplementary Table 1). The amount of mRNA was quantified 
against a standard curve using the Ct value.
Observation of aromatic compound degradation in culture. The reticuline-
producing strain was grown at 25 °C in Turbo Broth containing 10 µM of CuSO4 
and appropriate antibiotics without sugar. IPTG (50 µM) was added when OD600 
reached 10. At 12 h after IPTG induction, each substrate (final concentration: 0.5,  
2 and 8 mM dopamine, 7.5, 30 and 120 µM norlaudanosoline or 7.5, 30 and 120 µM 
reticuline) was added to the culture. The additive reticuline was enzymatically  
synthesized from 0.45 mM of norlaudanosoline using a crude extract of BL21 
(DE3) harbouring 6OMT-4′OMT-CNMT/pACYC184 (ref. 7). In all experiments, 
new synthesis of norlaudanosoline, mono- and di-methylated norlaudanosoline 
and reticuline were not observed.
Purification of (S)-reticuline. (S)-Reticuline was purified from culture medium 
with an Oasis HLB solid-phase extraction cartridge (Waters) and by HPLC. The 
cartridge was pre-equilibrated with water before loading the culture medium, 
washed with 5% methanol, and then (S)-reticuline eluted with 100% methanol. The 
eluent was subjected to HPLC equipped with a TSKgel ODS-80Ts column. Peak 
fractions corresponding to (S)-reticuline were collected, and the degree of refining 
confirmed by MS analysis. 
References
1.  Zhou, H., Xie, X. & Tang, Y. Engineering natural products using combinatorial 
biosynthesis and biocatalysis. Curr. Opin. Biotechnol. 19, 590–596 (2008).
2.  Chemler, J. A. & Koffas, M. A. Metabolic engineering for plant natural product 
biosynthesis in microbes. Curr. Opin. Biotechnol. 19, 597–605 (2008).
3.  Lee, S. Y., Kim, H. U., Park, J. H., Park, J. M. & Kim, T. Y. Metabolic engineering 
of microorganisms: general strategies and drug production. Drug Discov. Today 
14, 78–88 (2009).ARTICLE

NATuRE CoMMuNICATIoNS | DoI: 10.1038/ncomms1327
NATuRE CoMMuNICATIoNS | 2:326 | DoI: 10.1038/ncomms1327 | www.nature.com/naturecommunications
© 2011 Macmillan Publishers Limited. All rights reserved.
4.  Marner, W. D. Practical application of synthetic biology principles. Biotechnol. 
J. 4, 1406–1419 (2009).
5.  Schäfer, H. & Wink, M. Medicinally important secondary metabolites in 
recombinant microorganisms or plants: progress in alkaloid biosynthesis. 
Biotechnol. J. 4, 1684–1703 (2009).
6.  Kirby, J. & Keasling, J. D. Biosynthesis of plant isoprenoids: perspectives for 
microbial engineering. Annu. Rev. Plant Biol. 60, 335–355 (2009).
7.  Minami, H. et al. Microbial production of plant benzylisoquinoline alkaloids. 
Proc. Natl Acad. Sci. USA 105, 7393–7398 (2008).
8.  Hawkins, K. M. & Smolke, C. D. Production of benzylisoquinoline alkaloids in 
Saccharomyces cerevisiae. Nat. Chem. Biol. 4, 564–573 (2008).
9.  Horinouchi, S. Combinatorial biosynthesis of plant medicinal polyketides by 
microorganisms. Curr. Opin. Chem. Biol. 13, 197–204 (2009).
10. Keasling, J. From yeast to alkaloids. Nat. Chem. Biol. 4, 524–525 (2008).
11. Leonard, E., Runguphan, W., O’Connor, S. & Prather, K. J. Opportunities in 
metabolic engineering to facilitate scalable alkaloid production. Nat. Chem. 
Biol. 5, 292–300 (2009).
12. Pittard, J., Camakaris, H. & Yang, J. The TyrR regulon. Mol. Microbiol. 55, 
16–26 (2005).
13. Lütke-Eversloh, T., Santos, C. N. S. & Stephanopoulos, G. Perspectives of 
biotechnological production of L-tyrosine and its applications. Appl. Microbiol. 
Biotechnol. 77, 751–762 (2007).
14. Lütke-Eversloh, T. & Stephanopoulos, G. L-Tyrosine production by deregulated 
strains of Escherichia coli. Appl. Microbiol. Biotechnol. 75, 103–110 (2007).
15. Kohashi, P. Y. et al. An efficient method for the overexpression and purification 
of active tyrosinase from Streptomyces castaneoglobisporus. Protein Expr. Purif. 
34, 202–207 (2004).
16. Matoba, Y., Kumagai, T., Yamamoto, A., Yoshitsu, H. & Sugiyama, M. 
Crystallographic evidence that the dinuclear copper center of tyrosinase is 
flexible during catalysis. J. Biol. Chem. 281, 8981–8990 (2006).
17. Frenzela, T. & Zenk, M. H. S-Adenosyl-L-methionine: 3′-hydroxy-N-methyl-
(S)-coclaurine-4′-O-methyl transferase, a regio- and stereoselective enzyme of 
the (S)-reticuline pathway. Phytochemistry 29, 3505–3511 (1990).
18. Facchini, P. J., Huber-Allanach, K. L. & Tari, L. W. Plant aromatic L-amino acid 
decarboxylases: evolution, biochemistry, regulation, and metabolic engineering 
applications. Phytochemistry 54, 121–138 (2000).
19. Ahn, J. O. et al. Exploring the effects of carbon sources on the metabolic 
capacity for shikimic acid production in Escherichia coli using in silico 
metabolic predictions. J. Microbiol. Biotechnol. 18, 1773–1784 (2008).
20. Khamduang, M., Packdibamrung, K., Chutmanop, J., Chisti, Y. & Srinophakun, 
P. Production of L-phenylalanine from glycerol by a recombinant Escherichia 
coli. J. Ind. Microbiol. Biotechnol. 36, 1267–1274 (2009).
21. Hernández-Romero, D., Sanchez-Amat, A. & Solano, F. A tyrosinase with an 
abnormally high tyrosine hydroxylase/dopa oxidase ratio. FEBS J. 273, 257–270 (2006).
22. Frick, S. et al. Transformation of opium poppy (Papaver somniferum L.) with 
antisense berberine bridge enzyme gene (anti-bbe) via somatic embryogenesis 
results in an altered ratio of alkaloids in latex but not in roots. Transgenic Res. 
13, 607–613 (2004).
23. Nessler, C. L., Allen, R. D. & Galewsky, S. Identification and characterization of 
latex-specific proteins in opium poppy. Plant Physiol. 79, 499–504 (1985).
24. Hagel, J. M. & Facchini, P. J. Dioxygenases catalyze the O-demethylation steps 
of morphine biosynthesis in opium poppy. Nat. Chem. Biol. 6, 273–275 (2010).
25. Hirata, K., Poeaknapo, C., Schmidt, J. & Zenk, M. H. 1,2-Dehydroreticuline 
synthase, the branch point enzyme opening the morphinan biosynthetic 
pathway. Phytochemistry 65, 1039–1046 (2004).
26. De-Eknamkul, W. & Zenk, M. H. Purification and properties of 1,2-
dehydroreticuline reductase from Papaver somniferum seedlings. 
Phytochemistry 31, 813–821 (1992).
27. Chang, M. C. Y., Eachus, R. A., Trieu, W., Ro, D. K. & Keasling, J. D. 
Engineering Escherichia coli for production of functionalized terpenoids using 
plant P450s. Nat. Chem. Biol. 3, 274–277 (2007).
28. Ikeda, M. Towards bacterial strains overproducing L-tryptophan and other 
aromatics by metabolic engineering. Appl. Microbiol. Biotechnol. 69, 615–626 
(2006).
29. Datsenko, K. A. & Wanner, B. L. One-step inactivation of chromosomal genes 
in Escherichia coli K-12 using PCR products. Proc. Natl Acad. Sci. USA 97, 
6640–6645 (2000).
Acknowledgments
We thank Dr Francisco Solano (Murcia University, Spain) for his advice about RsTYR. 
This work was supported by Grants-in-Aid for Scientific Research on Innovative 
Areas (20200036 to H.M.), Young Scientists (B) (21780080 to H.M.), the Program for 
Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry 
(BRAIN) and in part by Scientific Research (A) (21248013 to F.S.).
Author contributions
A.N. and H.M. designed the study and conducted most of the experiments. J.S.K. and  
T. Koyanagi assisted with the experiments and associated analyses. F.S. and H.K. 
supervised the project. A.N, H.M., T. Katayama and F.S. wrote the manuscript.
Additional information
Supplementary Information accompanies this paper at http://www.nature.com/
naturecommunications
Competing financial interests: The authors declare no competing financial interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
How to cite this article: Nakagawa, A. et al. A bacterial platform for fermentative 
production of plant alkaloids. Nat. Commun. 2:326 doi: 10.1038/ncomms1327 (2011).
License: This work is licensed under a Creative Commons Attribution-NonCommercial-
Share Alike 3.0 Unported License. To view a copy of this license, visit http://
creativecommons.org/licenses/by-nc-sa/3.0/